Old Web
English
Sign In
Acemap
>
Paper
>
Bromocriptine decreases hepatic steatosis by modulation of the dopamine signaling in liver
Bromocriptine decreases hepatic steatosis by modulation of the dopamine signaling in liver
2019
Catia Barra
Ana Costa
Gabriela Tavares
Daniela Marques
Tiago Rodrigues
Joana F. Sacramento
Bernardete F. Melo
Raquel Seiça
Silvia Vilares-Conde
Paulo Matafome
Keywords:
Dopamine
Medicine
Bromocriptine
Internal medicine
Diabetes mellitus
Endocrinology
Steatosis
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]